Repro-Med Systems Stock Price, News & Analysis (OTCMKTS:REPR)

$1.30 +0.07 (+5.69 %)
(As of 02/16/2018 04:00 PM ET)
Previous Close$1.30
Today's Range$1.11 - $1.32
52-Week Range$0.34 - $1.32
Volume290,430 shs
Average Volume44,551 shs
Market Capitalization$49.19 million
P/E Ratio130.00
Dividend YieldN/A
Beta-0.66

About Repro-Med Systems (OTCMKTS:REPR)

REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company's products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator. The FREEDOM60 consists of the FREEDOM60 Syringe Infusion Pump and RMS Precision Flow Rate Tubing. The HIgH-Flo is designed for self-administration of medicine under the skin. The RES-Q-VAC is a hand-operated suction device that removes fluids from a patient's airway by attaching the RES-Q-VAC pump to various sterile and non-sterile single-use catheters sized for adult and pediatric suctioning. The On-Line Calculator is a tool to help determine which of the Company's Precision Flow Rate Tubing and RMS HIgH-Flo Subcutaneous Needle Sets are to be used based on the medication being administered and time of infusion.

Receive REPR News and Ratings via Email

Sign-up to receive the latest news and ratings for REPR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:REPR
CUSIPN/A
Phone+1-845-4692042

Debt

Debt-to-Equity RatioN/A
Current Ratio6.27%
Quick Ratio4.90%

Price-To-Earnings

Trailing P/E Ratio130
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$12.24 million
Price / Sales4.03
Cash Flow$0.01 per share
Price / Cash193.46
Book Value$0.18 per share
Price / Book7.22

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees69
Outstanding Shares37,930,000

Repro-Med Systems (OTCMKTS:REPR) Frequently Asked Questions

What is Repro-Med Systems' stock symbol?

Repro-Med Systems trades on the OTCMKTS under the ticker symbol "REPR."

Who are some of Repro-Med Systems' key competitors?

Who are Repro-Med Systems' key executives?

Repro-Med Systems' management team includes the folowing people:

  • Andrew I. Sealfon, Chairman of the Board, President (Age 70)
  • Fred Ma, Principal Executive Officer
  • Karen Fisher, Chief Financial Officer, Treasurer (Age 50)
  • David W. Anderson, Director (Age 63)
  • Paul Mark Baker, Director (Age 65)
  • Joseph M. Manko Jr., Additional Director (Age 50)
  • Mark L. Pastreich, Director (Age 86)
  • Arthur J. Radin CPA., Director (Age 79)

Who owns Repro-Med Systems stock?

Repro-Med Systems' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include HORTON CAPITAL PARTNERS, LLC (18.62%) and HORTON CAPITAL PARTNERS, LLC (17.08%). View Institutional Ownership Trends for Repro-Med Systems.

How do I buy Repro-Med Systems stock?

Shares of Repro-Med Systems can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Repro-Med Systems' stock price today?

One share of Repro-Med Systems stock can currently be purchased for approximately $1.30.

How big of a company is Repro-Med Systems?

Repro-Med Systems has a market capitalization of $49.19 million and generates $12.24 million in revenue each year. Repro-Med Systems employs 69 workers across the globe.

How can I contact Repro-Med Systems?

Repro-Med Systems' mailing address is 24 Carpenter Rd, CHESTER, NY 10918-1057, United States. The company can be reached via phone at +1-845-4692042 or via email at [email protected]


MarketBeat Community Rating for Repro-Med Systems (REPR)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  32 (Vote Underperform)
Total Votes:  60
MarketBeat's community ratings are surveys of what our community members think about Repro-Med Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Repro-Med Systems (OTCMKTS:REPR) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Repro-Med Systems (OTCMKTS:REPR) Earnings History and Estimates Chart

Earnings by Quarter for Repro-Med Systems (OTCMKTS:REPR)

Repro-Med Systems (OTCMKTS REPR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/27/2016Q4 2016$0.01ViewN/AView Earnings Details
5/18/2016Q1 2016$0.01ViewN/AView Earnings Details
10/2/2015Q3 2015$0.01ViewN/AView Earnings Details
5/8/2015Q1 2015$0.01ViewN/AView Earnings Details
10/15/2014Q3 2014$0.01ViewN/AView Earnings Details
5/29/2014Q1 2014$0.01ViewN/AView Earnings Details
5/29/2013Q1 2013$0.01ViewN/AView Earnings Details
10/15/2012Q3 2012$0.01ViewN/AView Earnings Details
5/29/2012Q1 2012$0.01ViewN/AView Earnings Details
1/17/2012Q4 2011$0.01ViewN/AView Earnings Details
7/15/2011Q2 2011$0.01ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Repro-Med Systems (OTCMKTS:REPR) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Repro-Med Systems (OTCMKTS:REPR)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Repro-Med Systems (OTCMKTS REPR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 39.00%
Insider Trades by Quarter for Repro-Med Systems (OTCMKTS:REPR)

Repro-Med Systems (OTCMKTS REPR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2017Joseph M Jr. MankoDirectorBuy396,692$0.89$353,055.88View SEC Filing  
12/12/2017Joseph M Jr. MankoDirectorBuy137,225$0.90$123,502.50View SEC Filing  
12/6/2017Joseph M Jr. MankoDirectorBuy50,811$0.84$42,681.24View SEC Filing  
11/30/2017Joseph M Jr. MankoDirectorBuy77,600$0.82$63,632.00View SEC Filing  
11/28/2017Joseph M Jr. MankoDirectorBuy222,710$0.80$178,168.00View SEC Filing  
11/10/2017Joseph M Jr. MankoDirectorBuy128,175$0.66$84,595.50View SEC Filing  
9/15/2017Joseph M Jr. MankoDirectorBuy146,418$0.50$73,209.00View SEC Filing  
5/30/2017Joseph M Jr. MankoDirectorBuy7,353$0.40$2,941.20View SEC Filing  
2/13/2017Joseph M Jr. MankoDirectorBuy30,000$0.40$12,000.00View SEC Filing  
2/2/2017Joseph M Jr. MankoDirectorBuy40,000$0.41$16,400.00View SEC Filing  
1/27/2017Joseph M Jr. MankoDirectorBuy7,700$0.43$3,311.00View SEC Filing  
1/25/2017Joseph M Jr. MankoDirectorBuy15,000$0.41$6,150.00View SEC Filing  
1/23/2017Joseph M Jr. MankoDirectorBuy45,000$0.42$18,900.00View SEC Filing  
1/17/2017Joseph M Jr. MankoDirectorBuy5,000$0.42$2,100.00View SEC Filing  
1/9/2017Joseph M Jr. MankoDirectorBuy22,500$0.43$9,675.00View SEC Filing  
1/3/2017Joseph M Jr. MankoDirectorBuy321,821$0.47$151,255.87View SEC Filing  
11/9/2016Joseph M Jr. MankoDirectorBuy9,700$0.41$3,977.00View SEC Filing  
11/4/2016Joseph M Jr. MankoDirectorBuy30,000$0.41$12,300.00View SEC Filing  
10/31/2016Joseph M Jr. MankoDirectorBuy25,400$0.44$11,176.00View SEC Filing  
10/18/2016Joseph M Jr. MankoDirectorBuy9,000$0.41$3,690.00View SEC Filing  
10/14/2016Joseph M Jr. MankoDirectorBuy10,100$0.43$4,343.00View SEC Filing  
10/11/2016Joseph M Jr. MankoDirectorBuy10,000$0.42$4,200.00View SEC Filing  
10/10/2016Joseph M Jr. MankoDirectorBuy32,500$0.43$13,975.00View SEC Filing  
10/3/2016Joseph M Jr. MankoDirectorBuy10,000$0.43$4,300.00View SEC Filing  
9/30/2016Joseph M Jr. MankoDirectorBuy136,248$0.44$59,949.12View SEC Filing  
8/15/2016Joseph M Jr. MankoDirectorBuy30,000$0.44$13,200.00View SEC Filing  
8/11/2016Joseph M Jr. MankoDirectorBuy20,000$0.44$8,800.00View SEC Filing  
8/1/2016Joseph M Jr. MankoDirectorBuy29,000$0.45$13,050.00View SEC Filing  
7/28/2016Joseph M Jr. MankoDirectorBuy20,000$0.43$8,600.00View SEC Filing  
7/26/2016Joseph M Jr. MankoDirectorBuy61,300$0.43$26,359.00View SEC Filing  
7/21/2016Joseph M Jr. MankoDirectorBuy18,800$0.44$8,272.00View SEC Filing  
7/12/2016Joseph M Jr. MankoDirectorBuy10,000$0.44$4,400.00View SEC Filing  
7/7/2016Joseph M Jr. MankoDirectorBuy10,000$0.44$4,400.00View SEC Filing  
7/6/2016Joseph M Jr. MankoDirectorBuy30,000$0.44$13,200.00View SEC Filing  
4/11/2016Joseph M Jr. MankoMajor ShareholderBuy15,000$0.31$4,650.00View SEC Filing  
2/16/2016Joseph M Jr. MankoMajor ShareholderBuy21,900$0.45$9,855.00View SEC Filing  
2/1/2016Joseph M Jr. MankoMajor ShareholderBuy28,800$0.45$12,960.00View SEC Filing  
1/28/2016Joseph M Jr. MankoMajor ShareholderBuy37,345$0.41$15,311.45View SEC Filing  
1/26/2016Joseph M Jr. MankoMajor ShareholderBuy34,500$0.42$14,490.00View SEC Filing  
1/22/2016Joseph M Jr. MankoMajor ShareholderBuy44,934$0.41$18,422.94View SEC Filing  
4/16/2013Remo SpagnoliDirectorBuy10,000$0.22$2,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Repro-Med Systems (OTCMKTS REPR) News Headlines

Source:
DateHeadline
RMS Medical Products Announces Results for Three, Ten and Twelve Months Ending December 31, 2017RMS Medical Products Announces Results for Three, Ten and Twelve Months Ending December 31, 2017
finance.yahoo.com - February 13 at 5:11 PM
Repro-Med Systems Inc.: RMS Medical Products Named to 2018 OTCQX Best 50Repro-Med Systems Inc.: RMS Medical Products Named to 2018 OTCQX Best 50
www.finanznachrichten.de - January 26 at 5:08 PM
RMS Medical Products Named to 2018 OTCQX Best 50RMS Medical Products Named to 2018 OTCQX Best 50
finance.yahoo.com - January 26 at 5:08 PM
Repro-Med Systems, Inc. (REPR) Director Joseph M. Jr. Manko Buys 396,692 SharesRepro-Med Systems, Inc. (REPR) Director Joseph M. Jr. Manko Buys 396,692 Shares
www.americanbankingnews.com - December 15 at 9:22 PM
Repro-Med Systems, Inc. (REPR) Director Joseph M. Jr. Manko Acquires 137,225 SharesRepro-Med Systems, Inc. (REPR) Director Joseph M. Jr. Manko Acquires 137,225 Shares
www.americanbankingnews.com - December 12 at 9:08 PM
Insider Buying: Repro-Med Systems, Inc. (REPR) Director Buys 50,811 Shares of StockInsider Buying: Repro-Med Systems, Inc. (REPR) Director Buys 50,811 Shares of Stock
www.americanbankingnews.com - December 7 at 6:44 PM
Insider Buying: Repro-Med Systems, Inc. (REPR) Director Buys 77,600 Shares of StockInsider Buying: Repro-Med Systems, Inc. (REPR) Director Buys 77,600 Shares of Stock
www.americanbankingnews.com - December 1 at 10:50 PM
Repro-Med Systems, Inc. (REPR) Director Buys $178,168.00 in StockRepro-Med Systems, Inc. (REPR) Director Buys $178,168.00 in Stock
www.americanbankingnews.com - November 28 at 7:52 PM
Repro-Med Systems Inc.: RMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational ChangesRepro-Med Systems Inc.: RMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational Changes
www.finanznachrichten.de - November 23 at 8:06 AM
RMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational ChangesRMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational Changes
finance.yahoo.com - November 23 at 8:06 AM
CORRECTION: RMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational ChangesCORRECTION: RMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational Changes
finance.yahoo.com - November 23 at 8:06 AM
RMS Medical Products Posts Strong Results for Three and Seven Months Ending September 30, 2017RMS Medical Products Posts Strong Results for Three and Seven Months Ending September 30, 2017
finance.yahoo.com - November 18 at 11:19 AM
Joseph M. Jr. Manko Buys 128,175 Shares of Repro-Med Systems Inc. (REPR) StockJoseph M. Jr. Manko Buys 128,175 Shares of Repro-Med Systems Inc. (REPR) Stock
www.americanbankingnews.com - November 13 at 6:30 PM

SEC Filings

Repro-Med Systems (OTCMKTS:REPR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Repro-Med Systems (OTCMKTS:REPR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Repro-Med Systems (OTCMKTS REPR) Stock Chart for Saturday, February, 17, 2018

Loading chart…

This page was last updated on 2/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.